# C3.ai, Inc. (AI) — Financial Analysis

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-12  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/AI/thesis · /stocks/AI/memo

## Financial Snapshot

---
source: coverage-next-full
ticker: AI
company: C3.ai, Inc.
step: 04
title: Financial Quality & Adversarial Sweep
created: 2026-06-11
---

### Step 04 — Financial Quality & Adversarial Sweep: C3.ai, Inc. (AI)

#### 1. Executive Summary

C3.ai's reported financials contain multiple flags warranting careful scrutiny: SBC exceeding revenue in FY2026, anomalous gross margin collapse, persistent GAAP losses despite a $700M+ cash cushion, and a history of customer concentration that inflated apparent growth metrics. The Adversarial Research Sweep below examines the most serious external allegations and accounting concerns. The core assessment: C3.ai's financial reporting appears technically compliant but paints an overly optimistic picture through non-GAAP exclusions of SBC. The real cash burn is obscured by interest income on the cash hoard. [S1]

#### 2. Statement Quality Adjustments

##### Income Statement Adjustments

| Item | Reported (FY2025) | Adjustment | Adjusted |
|------|------------------|-----------|---------|
| Operating Loss | (~$152M) | — | (~$152M) |
| Add back: SBC (non-cash) | $231M | -$231M SBC excluded | N/A (SBC is real cost) |
| Interest income | ~$60M | Remove — not operating | (~$212M) adjusted operating loss |
| **True operating cash burn** | — | — | **~($62M) FCF** (per 10-K) |

**Key insight:** GAAP operating loss of ~$152M looks severe, but FCF burn of only ~$47M (FY2025) shows the difference between GAAP (which expensing SBC in full) and cash reality. However, SBC is economically real — it dilutes shareholders. On a cash-adjusted, SBC-included (diluted) basis, the company burns ~$150M+/year economically.

**Non-GAAP vs. GAAP:** C3.ai reports non-GAAP operating metrics that exclude SBC. Management highlighted "non-GAAP operating loss" improving materially (from ~($90M) non-GAAP to closer to breakeven). This is technically accurate but excludes the company's single largest expense category. [S1]

##### Revenue Quality Assessment

| Concern | Evidence | Severity |
|---------|----------|---------|
| Baker Hughes concentration | BH was ~30%+ of revenue through FY2022; created artificial growth profile | High (historical) |
| IPD model ACV compression | 174 agreements vs. 49 prior = volume up 3.5x but revenue flat/declining = ACV -75%? | High |
| Channel stuffing risk | Rapid agreement volume growth with revenue declining — are deals real? | Medium (monitor) |
| Deferred revenue build | Not prominently flagged; subscription model should show deferred revenue growth | Low-Medium |
| Professional services low-margin | 16% mix at ~15% gross margin; if this grows, blended margin deteriorates | Medium |

#### 3. Balance Sheet Quality

##### Cash Position
| Date | Cash + Mkt Securities | Net Cash (vs. $0 debt) |
|------|----------------------|----------------------|
| FY2024 (Apr 2024) | ~$770M | ~$770M |
| FY2025 (Apr 2025) | ~$742M | ~$742M |
| Q4 FY2026 (Apr 2026, est.) | ~$673M | ~$673M |

Cash declined ~$70M over FY2025 (burn ≈ FCF burn of $47M + other) and another ~$69M over FY2026 YTD (Q3 FY2026 implied). The cash runway is substantial (>5 years at current burn rate), but the direction is negative.

##### Receivables / DSO
DSO estimation from XBRL not fully available, but professional services contracts and federal contracts can have extended payment terms (60–90+ days). Worth monitoring for FY2026 10-K.

##### Intangibles / Goodwill
C3.ai has minimal goodwill from acquisitions — the company has grown organically. No major goodwill impairment risk.

##### Operating Leases
Long-term operating leases (~$34M remaining per FY2025 10-K) for office space. No financial debt. Clean balance sheet from a leverage perspective.

#### 4. Adversarial Research Sweep

*Methodology: Web search for short seller reports, SEC investigations, class action lawsuits, whistleblower allegations, regulatory enforcement actions, and major accounting controversies related to C3.ai. No earnings transcripts loaded — relies on public filings, press coverage, and regulatory databases.*

---

##### Finding 1: Short Seller Reports (Multiple, 2021–2023)
**Source:** Multiple short-selling research publications; widely covered in financial press [S3]
**Allegation:** In 2021–2022, short sellers (including alleged Spruce Point Capital research coverage) questioned C3.ai's revenue recognition practices, particularly around the Baker Hughes alliance — alleging that the revenue was essentially a "barter" arrangement where Siebel and Baker Hughes CEO Lorenzo Simonelli had interlocking incentives. The allegation was that reported BH revenue was artificially inflated and would collapse once the relationship normalized.
**Current status:** The collapse of BH revenue (from $92M to $16M by FY2024) largely validated the concern — it was a related-party distortion, not organic customer demand. C3.ai disclosed this as a related-party transaction and wound it down properly. No SEC enforcement action resulted.
**Severity:** RESOLVED (the distortion is now in the past). The bear case was right — BH revenue was not reproducible.

---

##### Finding 2: IPO Lock-Up / Insider Selling Pattern
**Source:** Form 4 filings via SEC EDGAR [S4]
**Allegation:** Not an allegation per se, but 38 Form 4 filings for Tom Siebel with zero purchases since 2021 — all sales. Systematic liquidation via 10b5-1 plan. Remaining ownership ~9.1M shares down from original post-IPO holdings.
**Interpretation:** While 10b5-1 plans can be set up in good faith, the consistent selling pattern with no purchases is a negative signal for long-term conviction from the founder. The CEO transition to Ehikian with Siebel remaining as Executive Chairman may be a succession pathway or may indicate Siebel's reduced commitment.
**Severity:** MEDIUM — ongoing overhang; not fraud, but negative governance signal.

---

##### Finding 3: Revenue Recognition and IPD Model Integrity
**Source:** FY2024 and FY2025 10-K risk factor disclosures [S1]
**Concern:** The shift to Individual Purchase Agreements (IPDs) — consumption-based contracts — creates revenue recognition timing variability. Unlike traditional SaaS ARR, consumption revenue can be lumpy. The dramatic Q3 FY2026 revenue step-down (-44% YoY, -29% sequentially) could indicate:
1. CEO transition disrupting sales organization (legitimate operational issue)
2. IPD contracts not renewing / customers consuming less than contracted
3. A federal contract timing gap (contracts delayed by CR/budget uncertainty)
4. Channel conflict between partner-led and direct sales during transition
**Evidence for/against fraud:** No SEC investigation; 10-K disclosures are detailed and disclose all material customer concentration. Audit firm (KPMG) has not flagged material weaknesses.
**Severity:** MEDIUM-HIGH — not fraud, but the Q3 FY2026 step-down needs management explanation (available in earnings call transcript, which is not loaded here).

---

##### Finding 4: Class Action Lawsuits
**Source:** Legal databases; press coverage [S3]
**Status:** C3.ai faced securities class action litigation in 2023 related to alleged misrepresentations about growth prospects and the Baker Hughes relationship. Settlement status as of research date unknown. Management disclosed the litigation in FY2024/FY2025 10-K risk factors.
**Financial impact:** Any settlement would be a one-time charge; no indication of material financial impact.
**Severity:** LOW-MEDIUM (ongoing legal risk, not existential).

---

##### Finding 5: SBC > Revenue (FY2026)
**Source:** StockAnalysis.com FY2026 data; SEC XBRL SBC trend [S2]
**Concern:** If FY2026 SBC is ~$264M on ~$250M revenue, this is economically unsustainable. Large new CEO grants to Ehikian + leadership refresh likely drove this spike. However:
- Grants to new executives are typically front-loaded and amortized over vesting schedules
- Future SBC should decline as grants vest (if no new major refresh occurs)
- The company will need to disclose SBC trajectory in the FY2026 10-K
**Severity:** HIGH (dilution risk) — but may be transient if driven by CEO onboarding grants.

---

#### 5. Audit Quality Assessment

- **Auditor:** KPMG LLP (Big 4)
- **Audit opinions:** Unqualified in FY2025 and FY2024 10-K
- **Material weaknesses:** None disclosed in recent filings
- **Related-party disclosures:** Adequately disclosed (Baker Hughes, board members)
- **Revenue recognition policy:** ASC 606 compliant; subscription and PS revenue recognized separately

Overall audit quality: **Satisfactory**. No red flags in audit opinions. The Baker Hughes related-party transaction was properly disclosed throughout.

#### 6. Cash Burn Analysis

| FY | Operating CF | CapEx | FCF | Cash Balance EOY |
|----|-------------|-------|-----|-----------------|
| FY2022 | ($94M) | ($20M) | ($114M) | — |
| FY2023 | ($79M) | ($22M) | ($101M) | — |
| FY2024 | ($68M) | ($25M) | ($90M) | ~$770M |
| FY2025 | ($44M) | ($3M) | ($47M) | ~$742M |
| FY2026 est. | ($60–80M est.) | — | (~$65M est.) | ~$673M |

**FCF improving trend (FY2022→FY2025):** From -$114M to -$47M — genuine improvement driven by operating leverage. However, FY2026 may reverse this as revenue declines faster than costs.

**Cash runway:** At $673M cash and ~$65M/year burn rate, C3.ai has ~10+ years of runway — not an existential concern.

#### 7. Source Index

| ID | Source | Detail |
|----|--------|--------|
| S1 | FY2025 10-K | P&L, risk factors, non-GAAP disclosures, audit opinion |
| S2 | StockAnalysis.com, XBRL SBC data | FY2026 SBC estimate; historical SBC trend |
| S3 | Press coverage, legal databases | Short seller reports, class action |
| S4 | SEC Form 4 filings | Insider transaction history (38 Form 4s) |
| S5 | FY2024 10-K | Baker Hughes related-party disclosure; litigation disclosures |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/AI/fundamental

## Navigation

- Overview: /stocks/AI
- Financials (this page): /stocks/AI/financials
- Thesis: /stocks/AI/thesis
- Investment Memo: /stocks/AI/memo
- Coverage universe: /stocks